Stelara for Crohn’s Disease
Stelara, a treatment for Crohn’s Disease, saw 40% of clinical trial patients achieve remission by the 8th week.
Stelara for Crohn’s Disease
Rituxan for ANCA Associated Vasculitis
Orencia for Psoriatic Arthritis
Actemra for Giant Cell Arteritis
Simponi Aria for Rheumatoid Arthritis
Injectafer for Iron Deficiency Anemia
Prolia for Osteoporosis
Krystexxa for Gout
Benlysta For Lupus
Ocrevus for MS
Remicade for Crohn’s Disease
Reclast for Osteoporosis